Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
2,203 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| 56S1.DE | Sartorius Stedim Biotech S.A. | Healthcare | $21.77B | 194.20 EUR | −13.11% | +13.30% |
| SIG.AX | Sigma Healthcare Limited | Healthcare | $21.65B | 2.59 AUD | −19.06% | −13.09% |
| GMAB | Genmab A/S | Healthcare | $21.42B | $33.75 | −4.74% | +16.38% |
| GMAB.CO | Genmab A/S | Healthcare | $20.69B | 2,196.00 DKK | −2.70% | +17.62% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| GE9.DE | Genmab A/S | Healthcare | $20.65B | 294.20 EUR | −11.12% | +17.26% |
| S1TE34.SA | STERIS plc | Healthcare | $19.75B | 52.14 BRL | −19.78% | 0.00% |
| SRT3.DE | Sartorius Aktiengesellschaft | Healthcare | $19.68B | 246.50 EUR | −7.92% | +9.26% |
| VIA.DE | Viatris Inc. | Healthcare | $19.41B | 14.27 EUR | −10.03% | −9.28% |
| VTRS | Viatris Inc. | Healthcare | $19.35B | $16.85 | −8.37% | −5.66% |
| ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $19.34B | $101.38 | −6.38% | +5.88% |
| QS51.DE | Straumann Holding AG | Healthcare | $18.40B | 98.00 EUR | −17.65% | −5.77% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | Healthcare | $18.07B | 121.92 BRL | −5.55% | +6.75% |
| MEDP | Medpace Holdings, Inc. | Healthcare | $17.28B | $619.05 | −8.68% | +8.42% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | Healthcare | $16.99B | 469.60 SEK | −3.57% | −0.76% |
| JAZZ | Jazz Pharmaceuticals plc | Healthcare | $16.89B | $249.29 | −6.42% | −2.97% |
| ASND | Ascendis Pharma A/S | Healthcare | $16.41B | $250.25 | −11.31% | −1.65% |
| IPN.PA | Ipsen S.A. | Healthcare | $15.97B | 166.00 EUR | −4.32% | +1.41% |
| COLO-B.CO | Coloplast A/S | Healthcare | $15.96B | 462.50 DKK | −28.47% | +6.22% |
| CBHD.DE | Coloplast A/S | Healthcare | $15.94B | 61.54 EUR | −28.17% | +5.85% |
| NBIX | Neurocrine Biosciences, Inc. | Healthcare | $15.92B | $156.59 | −15.87% | −14.35% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | Healthcare | $15.65B | 39.64 BRL | −13.41% | −10.88% |
| SOLV | Solventum Corporation | Healthcare | $15.58B | $91.53 | −1.27% | +6.22% |
| SRT.DE | Sartorius Aktiengesellschaft | Healthcare | $15.54B | 195.00 EUR | −6.25% | +9.92% |
| BBIO | BridgeBio Pharma, Inc. | Healthcare | $15.52B | $79.37 | −15.04% | −7.22% |
| 4507.T | Shionogi & Co., Ltd. | Healthcare | $15.45B | 2,892.00 JPY | −23.04% | −5.80% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | Healthcare | $15.44B | 36.47 AUD | −3.29% | +5.19% |
| C1OO34.SA | The Cooper Companies, Inc. | Healthcare | $15.12B | 39.92 BRL | −15.06% | +6.97% |
| RDOR3.SA | Rede D'Or São Luiz S.A. | Healthcare | $14.92B | 35.30 BRL | −27.08% | +2.86% |
| ESF0.DE | Eurofins Scientific SE | Healthcare | $14.67B | 72.70 EUR | −2.15% | +7.58% |
| ERF.PA | Eurofins Scientific SE | Healthcare | $14.64B | 74.08 EUR | −0.32% | +7.93% |
| 7733.T | Olympus Corporation | Healthcare | $14.46B | 2,162.50 JPY | −2.17% | +16.11% |
| COO | The Cooper Companies, Inc. | Healthcare | $14.25B | $72.68 | −19.09% | +0.86% |
| CRL | Charles River Laboratories International, Inc. | Healthcare | $14.09B | $295.10 | −1.83% | +22.74% |
| EXEL | Exelixis, Inc. | Healthcare | $14.05B | $56.10 | −2.55% | −0.73% |
| RVTY | Revvity, Inc. | Healthcare | $13.93B | $126.35 | −0.43% | +13.31% |
| BAX | Baxter International Inc. | Healthcare | $13.70B | $26.50 | −11.67% | +8.74% |
| PME.AX | Pro Medicus Limited | Healthcare | $13.66B | 181.86 AUD | −43.45% | +10.93% |
| B1AX34.SA | Baxter International Inc. | Healthcare | $13.60B | 67.70 BRL | −7.60% | +8.81% |
| ORNBV.HE | Orion Oyj | Healthcare | $13.16B | 80.80 EUR | −2.42% | −1.76% |
| ORNAV.HE | Orion Oyj | Healthcare | $13.11B | 80.50 EUR | −2.66% | −1.83% |
| ICLR | ICON Public Limited Company | Healthcare | $13.03B | $168.93 | −17.15% | −6.27% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | $12.95B | $119.80 | −5.21% | +27.19% |
| S1NN34.SA | Smith & Nephew plc | Healthcare | $12.87B | 31.62 BRL | −22.27% | 0.00% |
| PEN | Penumbra, Inc. | Healthcare | $12.72B | $323.05 | −10.86% | +0.96% |
| BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $12.70B | $65.61 | −7.57% | +5.70% |
| FME.DE | Fresenius Medical Care AG | Healthcare | $12.64B | 40.36 EUR | −15.67% | −7.39% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | Healthcare | $12.57B | 52.70 EUR | −4.44% | +2.53% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | Healthcare | $12.54B | 166.77 BRL | −4.38% | +12.08% |
| ELAN | Elanco Animal Health Incorporated | Healthcare | $12.53B | $25.08 | −10.36% | −1.72% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | $12.52B | $89.12 | −6.67% | +3.89% |
| FMS | Fresenius Medical Care AG | Healthcare | $12.51B | $23.40 | −15.34% | −5.45% |
| R1VT34.SA | Revvity, Inc. | Healthcare | $12.50B | 20.60 BRL | −7.37% | +3.00% |
| MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | $12.45B | $538.88 | −12.38% | +0.01% |
| HALO | Halozyme Therapeutics, Inc. | Healthcare | $12.41B | $107.06 | −2.36% | +28.29% |
| TEM | Tempus AI, Inc. | Healthcare | $12.40B | $68.48 | −34.36% | +59.63% |
| SNN | Smith & Nephew plc | Healthcare | $12.23B | $29.30 | −24.47% | −10.01% |
| SN.L | Smith & Nephew plc | Healthcare | $12.18B | 1,068.00 GBP | −25.91% | −12.06% |
| EHC | Encompass Health Corporation | Healthcare | $11.92B | $120.78 | −5.63% | +4.09% |
| DVAI34.SA | DaVita Inc. | Healthcare | $11.70B | 938.25 BRL | −25.14% | −23.86% |
| T1CH34.SA | Bio-Techne Corporation | Healthcare | $11.51B | 12.60 BRL | 0.00% | +4.13% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.